The outcome of patients with simultaneous diagnosis of haematological malignancies (HM) and COVID-19 is unknown and there are no specific treatment guidelines.
Cattaneo, C., Salmanton-García, J., Marchesi, F., El-Ashwah, S., Itri, F., Weinbergerová, B., et al. (2022). Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey. CANCERS, 14(22), 5530 [10.3390/cancers14225530].
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Del Principe, Maria Ilaria;
2022-11-10
Abstract
The outcome of patients with simultaneous diagnosis of haematological malignancies (HM) and COVID-19 is unknown and there are no specific treatment guidelines.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.